Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-29 | Mr. Sherman holds a B.A. in economics from DePauw University and an M.B.A. from the Amos Tuck School, Dartmouth College. |
| 2020-04-28 | Mr. Sherman holds a B.A. in economics from DePauw University and an M.B.A. from the Amos Tuck School, Dartmouth College. |
| 2021-04-28 | Mr. Sherman holds a B.A. in economics from DePauw University and an MBA from the Tuck School of Business at Dartmouth. |
| 2022-04-28 | Mr. Sherman holds a B.A. in economics from DePauw University and an MBA from the Tuck School of Business at Dartmouth. |
| Filing Date | Source Excerpt |
|---|---|
| 2018-06-15 | Mr. Sherman has worked in finance for over 30 years, having last served as a Managing Director in Investment Banking, at Barclays Plc. Prior to Barclays, Mr. Sherman was at Lehman Brothers, Inc. and Salomon Brothers Inc. Mr. Sherman began his career in finance as a lawyer at Cleary, Gottlieb, Steen & Hamilton. |
| 2019-04-22 | He has worked in finance for over 30 years, having last served as a Managing Director in Investment Banking, at Barclays Plc. Prior to Barclays, Mr. Sherman was at Lehman Brothers, Inc. and Salomon Brothers Inc. Mr. Sherman began his career in finance as a lawyer. |
| 2020-06-11 | Mr. Sherman specialized in equity capital markets and covered Healthcare companies, in addition to companies in other sectors. Mr. Sherman began his career in finance as a lawyer at Cleary, Gottlieb, Steen & Hamilton in New York City and Hong Kong. |
| 2021-06-30 | Mr. Sherman specialized in equity capital markets and covered Healthcare companies, in addition to companies in other sectors. Mr. Sherman also is currently a Board Member at BioVie, Inc., a specialty pharmaceutical company. |
| 2022-01-28 | Michael Sherman is listed as a director with stock options, but no software or technical skills are described. |
| 2022-07-25 | Mr. Sherman specialized in equity capital markets and covered Healthcare companies, in addition to companies in other sectors. Mr. Sherman also is currently a Board Member at BioVie, Inc., a specialty pharmaceutical company. |
| 2023-01-20 | Michael Sherman 15,550 — 15,550 * |
| 2023-08-30 | Mr. Sherman has worked in finance for over 30 years, having last served as a Managing Director in Investment Banking, at Barclays Plc. He began his career as a lawyer at Cleary, Gottlieb, Steen & Hamilton. |
Data sourced from SEC filings. Last updated: 2026-02-03